vs

Side-by-side financial comparison of Mister Car Wash, Inc. (MCW) and Ultragenyx Pharmaceutical Inc. (RARE). Click either name above to swap in a different company.

Mister Car Wash, Inc. is the larger business by last-quarter revenue ($261.2M vs $207.3M, roughly 1.3× Ultragenyx Pharmaceutical Inc.). Mister Car Wash, Inc. runs the higher net margin — 7.7% vs -62.0%, a 69.7% gap on every dollar of revenue. On growth, Ultragenyx Pharmaceutical Inc. posted the faster year-over-year revenue change (25.9% vs 4.0%). Mister Car Wash, Inc. produced more free cash flow last quarter ($-16.8M vs $-100.8M). Over the past eight quarters, Ultragenyx Pharmaceutical Inc.'s revenue compounded faster (38.0% CAGR vs 4.5%).

Brown Bear Car Wash is an American car wash chain based in Washington state. Founded in Seattle in 1957, it is the 12th largest car wash chain in the United States with 49 locations as of 2021.

Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.

MCW vs RARE — Head-to-Head

Bigger by revenue
MCW
MCW
1.3× larger
MCW
$261.2M
$207.3M
RARE
Growing faster (revenue YoY)
RARE
RARE
+21.9% gap
RARE
25.9%
4.0%
MCW
Higher net margin
MCW
MCW
69.7% more per $
MCW
7.7%
-62.0%
RARE
More free cash flow
MCW
MCW
$84.0M more FCF
MCW
$-16.8M
$-100.8M
RARE
Faster 2-yr revenue CAGR
RARE
RARE
Annualised
RARE
38.0%
4.5%
MCW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MCW
MCW
RARE
RARE
Revenue
$261.2M
$207.3M
Net Profit
$20.1M
$-128.6M
Gross Margin
Operating Margin
15.8%
-54.7%
Net Margin
7.7%
-62.0%
Revenue YoY
4.0%
25.9%
Net Profit YoY
118.9%
3.5%
EPS (diluted)
$0.06
$-1.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCW
MCW
RARE
RARE
Q4 25
$261.2M
$207.3M
Q3 25
$263.4M
$159.9M
Q2 25
$265.4M
$166.5M
Q1 25
$261.7M
$139.3M
Q4 24
$251.2M
$164.6M
Q3 24
$249.3M
$139.5M
Q2 24
$255.0M
$147.0M
Q1 24
$239.2M
$108.8M
Net Profit
MCW
MCW
RARE
RARE
Q4 25
$20.1M
$-128.6M
Q3 25
$27.4M
$-180.4M
Q2 25
$28.6M
$-115.0M
Q1 25
$27.0M
$-151.1M
Q4 24
$9.2M
$-133.2M
Q3 24
$22.3M
$-133.5M
Q2 24
$22.1M
$-131.6M
Q1 24
$16.6M
$-170.7M
Operating Margin
MCW
MCW
RARE
RARE
Q4 25
15.8%
-54.7%
Q3 25
19.7%
-106.9%
Q2 25
20.4%
-64.8%
Q1 25
20.2%
-102.6%
Q4 24
12.7%
-74.3%
Q3 24
19.9%
-94.6%
Q2 24
21.6%
-79.1%
Q1 24
17.8%
-151.9%
Net Margin
MCW
MCW
RARE
RARE
Q4 25
7.7%
-62.0%
Q3 25
10.4%
-112.8%
Q2 25
10.8%
-69.0%
Q1 25
10.3%
-108.5%
Q4 24
3.7%
-80.9%
Q3 24
9.0%
-95.7%
Q2 24
8.7%
-89.5%
Q1 24
7.0%
-156.8%
EPS (diluted)
MCW
MCW
RARE
RARE
Q4 25
$0.06
$-1.28
Q3 25
$0.08
$-1.81
Q2 25
$0.09
$-1.17
Q1 25
$0.08
$-1.57
Q4 24
$0.02
$-1.34
Q3 24
$0.07
$-1.40
Q2 24
$0.07
$-1.52
Q1 24
$0.05
$-2.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCW
MCW
RARE
RARE
Cash + ST InvestmentsLiquidity on hand
$28.4M
$421.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$-80.0M
Total Assets
$3.2B
$1.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCW
MCW
RARE
RARE
Q4 25
$28.4M
$421.0M
Q3 25
$35.7M
$202.5M
Q2 25
$26.4M
$176.3M
Q1 25
$39.1M
$127.1M
Q4 24
$67.5M
$174.0M
Q3 24
$16.5M
$150.6M
Q2 24
$3.6M
$480.7M
Q1 24
$10.7M
$112.3M
Stockholders' Equity
MCW
MCW
RARE
RARE
Q4 25
$1.1B
$-80.0M
Q3 25
$1.1B
$9.2M
Q2 25
$1.1B
$151.3M
Q1 25
$1.0B
$144.2M
Q4 24
$998.4M
$255.0M
Q3 24
$979.4M
$346.8M
Q2 24
$949.4M
$432.4M
Q1 24
$928.7M
$140.3M
Total Assets
MCW
MCW
RARE
RARE
Q4 25
$3.2B
$1.5B
Q3 25
$3.1B
$1.2B
Q2 25
$3.1B
$1.3B
Q1 25
$3.1B
$1.3B
Q4 24
$3.1B
$1.5B
Q3 24
$3.0B
$1.5B
Q2 24
$3.0B
$1.6B
Q1 24
$2.9B
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCW
MCW
RARE
RARE
Operating Cash FlowLast quarter
$60.0M
$-99.8M
Free Cash FlowOCF − Capex
$-16.8M
$-100.8M
FCF MarginFCF / Revenue
-6.4%
-48.6%
Capex IntensityCapex / Revenue
29.4%
0.5%
Cash ConversionOCF / Net Profit
2.99×
TTM Free Cash FlowTrailing 4 quarters
$30.3M
$-472.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCW
MCW
RARE
RARE
Q4 25
$60.0M
$-99.8M
Q3 25
$91.4M
$-91.4M
Q2 25
$46.8M
$-108.3M
Q1 25
$87.5M
$-166.5M
Q4 24
$49.8M
$-79.3M
Q3 24
$80.0M
$-67.0M
Q2 24
$60.9M
$-77.0M
Q1 24
$58.0M
$-190.7M
Free Cash Flow
MCW
MCW
RARE
RARE
Q4 25
$-16.8M
$-100.8M
Q3 25
$25.8M
$-92.7M
Q2 25
$-11.2M
$-110.7M
Q1 25
$32.5M
$-167.8M
Q4 24
$-20.4M
$-79.5M
Q3 24
$-16.8M
$-68.6M
Q2 24
$-20.4M
$-79.0M
Q1 24
$-23.9M
$-193.9M
FCF Margin
MCW
MCW
RARE
RARE
Q4 25
-6.4%
-48.6%
Q3 25
9.8%
-58.0%
Q2 25
-4.2%
-66.5%
Q1 25
12.4%
-120.5%
Q4 24
-8.1%
-48.3%
Q3 24
-6.8%
-49.2%
Q2 24
-8.0%
-53.7%
Q1 24
-10.0%
-178.2%
Capex Intensity
MCW
MCW
RARE
RARE
Q4 25
29.4%
0.5%
Q3 25
24.9%
0.8%
Q2 25
21.9%
1.5%
Q1 25
21.1%
1.0%
Q4 24
27.9%
0.1%
Q3 24
38.8%
1.2%
Q2 24
31.9%
1.4%
Q1 24
34.2%
3.0%
Cash Conversion
MCW
MCW
RARE
RARE
Q4 25
2.99×
Q3 25
3.33×
Q2 25
1.64×
Q1 25
3.24×
Q4 24
5.43×
Q3 24
3.58×
Q2 24
2.76×
Q1 24
3.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCW
MCW

Transferred Over Time$205.7M79%
Transferred At Point In Time$55.2M21%

RARE
RARE

Royalty$105.6M51%
Products$101.7M49%

Related Comparisons